Physician profile
Bridget C Fox
NPI 1417026964
$2,442.69
in general payments reported to CMS, 2019-2025
23 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $532 · 2022: $499 · 2023: $712 · 2024: $536 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $762.99 | 2021-2024 | |
| Abbott Laboratories | $181.06 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $174.63 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $167.28 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $141.06 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $123.07 | 2021-2025 | |
| Amarin Pharma, INC. | $122.61 | 2021 | |
| Phathom Pharmaceuticals, INC. | $116.20 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $104.82 | 2022-2024 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $89.52 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $80.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.15 | 2023 | |
| Exact Sciences Corporation | $53.53 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $53.38 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $41.17 | 2021-2024 | Vaxelis, Gardasil 9, Capvaxive |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $37.72 | 2023 | Gemtesa |
| Inari Medical, INC. | $24.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Halozyme INC | $23.76 | 2023 | |
| Corium, LLC | $22.69 | 2023 | Azstarys |
| Dexcom, INC. | $20.74 | 2024 | Dexcom G6 Transmitter |
| Amgen INC. | $17.62 | 2023 | Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $11.71 | 2022 | |
| Genentech USA, INC. | $2.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.